Skip to content

CALMARE THERAPEUTICS INC

CIK 0000102198

← back to feed
Revenue (TTM)
$1.9M
+1,929.8% YoY FY Jul 2017
Net Income (TTM)
−$3.7M
−4.1% YoY FY Jul 2017
EPS Diluted (TTM)
−$0.17
+20.0% YoY FY Jul 2017
Gross Margin
34.4%
FY Jul 2017
Operating Margin
-115.5%
FY Jul 2017
Net Margin
-194.6%
FY Jul 2017
Free Cash Flow (TTM)
−$1.38M
FY Jul 2017
Cash
$12.55K
FY Jul 2017
Total Debt
$20K
FY Jul 2017
Shares Outstanding
30.38M sh
FY Jul 2017

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings